These pathways are closely related to the occurrence of insulin resistance, which is the main pathogenic factor of T2DM, manifesting in a decreasing insulin sensitivity of target tissues (liver, skeletal muscle, and fat), resulting in a decreased ability for glucose absorption [25]. The gene discussed is INS; the disease is type 2 diabetes mellitus.